Testing effectiveness (Phase 2)Ended earlyNCT00267007
What this trial is testing
Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Who this might be right for
Peripheral Neuropathy, Chemotherapy-induced
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 32